siRNA, Anti-PAX1, LNA-modified(CAT#: SIRGT19219WQ-LNA)

The product SIRGT19219WQ-LNA is a type of small interfering RNA (siRNA) that targets PAX1 gene and regulates the expression of gene. The siRNA interferes with the expression of PAX1 gene with complementary nucleotide sequences by degrading mRNA after transcription, preventing translation. The siRNA is systematically modified with the synthetic RNA-like high affinity nucleotide analogue, Locked Nucleic Acid (LNA), to improve its bio-stability, specificity and efficiency. It has potential applications in RNA interference (RNAi) and gene therapy development.

Specifications
Modification Locked Nucleic Acid (LNA)
Scale 20/50/100/200 nmole
NCBI RefSeq NM_001257096.1; NM_006192.4
Alternative Names HUP48; OFC2
Related Diseases Vertebral malformations
Purification HPLC
Target Gene
Gene ID 5075
Uniprot ID P15863

Related Products